Hoyoung Maeng - Search Results

Year	Number of Results
2003	2
2004	3
2006	1
2007	1
2008	1
2009	4
2011	1
2013	1
2016	1
2018	2
2019	1
2020	1
2021	0

1

Strategies for developing and optimizing cancer vaccines.

Maeng HM, Berzofsky JA. Maeng HM, et al. F1000Res. 2019 May 13;8:F1000 Faculty Rev-654. doi: 10.12688/f1000research.18693.1. eCollection 2019. F1000Res. 2019. PMID: 31131086 Free PMC article. Review.

2

Cancer vaccines: translation from mice to human clinical trials.

Maeng H, Terabe M, Berzofsky JA. Maeng H, et al. Curr Opin Immunol. 2018 Apr;51:111-122. doi: 10.1016/j.coi.2018.03.001. Epub 2018 Mar 16. Curr Opin Immunol. 2018. PMID: 29554495 Free PMC article. Review.

3

Diversity Outbred Mice Reveal the Quantitative Trait Locus and Regulatory Cells of HER2 Immunity.

Wei WZ, Gibson HM, Jacob JB, Frelinger JA, Berzofsky JA, Maeng H, Dyson G, Reyes JD, Pilon-Thomas S, Ratner S, Wei KC. Wei WZ, et al. Among authors: maeng h. J Immunol. 2020 Sep 15;205(6):1554-1563. doi: 10.4049/jimmunol.2000466. Epub 2020 Aug 12. J Immunol. 2020. PMID: 32796024 Free PMC article.

4

JAK2 V617F/C618R mutation in a patient with polycythemia vera: a case study and review of the literature.

Yoo JH, Park TS, Maeng HY, Sun YK, Kim YA, Kie JH, Cho EH, Song J, Lee KA, Suh B, Choi JR. Yoo JH, et al. Cancer Genet Cytogenet. 2009 Feb;189(1):43-7. doi: 10.1016/j.cancergencyto.2008.09.010. Cancer Genet Cytogenet. 2009. PMID: 19167611 Review.

5

Oxidative status in iron-deficiency anemia.

Yoo JH, Maeng HY, Sun YK, Kim YA, Park DW, Park TS, Lee ST, Choi JR. Yoo JH, et al. J Clin Lab Anal. 2009;23(5):319-23. doi: 10.1002/jcla.20335. J Clin Lab Anal. 2009. PMID: 19774625 Free PMC article. Clinical Trial.

6

Long-term results of a phase II trial of lenalidomide plus prednisone therapy for patients with myelofibrosis.

Chihara D, Masarova L, Newberry KJ, Maeng H, Ravandi F, Garcia-Manero G, Ferrajoli A, Cortes J, Kantarjian H, Verstovsek S. Chihara D, et al. Among authors: maeng h. Leuk Res. 2016 Sep;48:1-5. doi: 10.1016/j.leukres.2016.06.007. Epub 2016 Jun 23. Leuk Res. 2016. PMID: 27416326 Free PMC article. Clinical Trial.

7

Nucleolin inhibits Fas ligand binding and suppresses Fas-mediated apoptosis in vivo via a surface nucleolin-Fas complex.

Wise JF, Berkova Z, Mathur R, Zhu H, Braun FK, Tao RH, Sabichi AL, Ao X, Maeng H, Samaniego F. Wise JF, et al. Among authors: maeng h. Blood. 2013 Jun 6;121(23):4729-39. doi: 10.1182/blood-2012-12-471094. Epub 2013 Apr 18. Blood. 2013. PMID: 23599269 Free PMC article.

8

K1 protein of human herpesvirus 8 suppresses lymphoma cell Fas-mediated apoptosis.

Wang S, Wang S, Maeng H, Young DP, Prakash O, Fayad LE, Younes A, Samaniego F. Wang S, et al. Among authors: maeng h. Blood. 2007 Mar 1;109(5):2174-82. doi: 10.1182/blood-2006-02-003178. Epub 2006 Nov 7. Blood. 2007. PMID: 17090655 Free PMC article.

9

Constitutive phosphorylation of FKHR transcription factor as a prognostic variable in acute myeloid leukemia.

Cheong JW, Eom JI, Maeng HY, Lee ST, Hahn JS, Ko YW, Min YH. Cheong JW, et al. Leuk Res. 2003 Dec;27(12):1159-62. doi: 10.1016/s0145-2126(03)00102-4. Leuk Res. 2003. PMID: 12921955

10

Mechanism of Fas signaling regulation by human herpesvirus 8 K1 oncoprotein.

Berkova Z, Wang S, Wise JF, Maeng H, Ji Y, Samaniego F. Berkova Z, et al. Among authors: maeng h. J Natl Cancer Inst. 2009 Mar 18;101(6):399-411. doi: 10.1093/jnci/djn516. Epub 2009 Mar 10. J Natl Cancer Inst. 2009. PMID: 19276446 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results